China approves emergency use of Sinovac's Covid-19 vaccine in children, adolescents

Preliminary results from Phase I and II clinical trials show the vaccine could trigger immune response in 3- to 17-year-old participants

China approves emergency use of Sinovac's Covid-19 vaccine in children, adolescents

State-backed drugmaker Sinopharm, which has two shots using similar technology to Sinovac's product, is also submitting data for clearance in younger groups. Reuters file

Beijing, June 5

China has approved emergency use of Sinovac Biotech's COVID-19 vaccine in people aged between three and 17, its chairman Yin Weidong told state TV late on Friday.

China's mass vaccination drive, which administered 723.5 million doses of vaccines as of June 3, is currently only open to those aged 18 and above.

When Sinovac's vaccine will be offered to younger groups depends on health authorities formulating China's inoculation strategies, Yin told state TV in an live interview.

Yin said minors have lower priority for vaccination against the coronavirus compared with the elderly, who face higher risk of severe symptoms after infection.

Preliminary results from Phase I and II clinical trials showed the vaccine could trigger immune response in three to 17 year-old participants, and most adverse reactions were mild.

State-backed drugmaker Sinopharm, which has two shots using similar technology to Sinovac's product, is also submitting data for clearance in younger groups. A vaccine from CanSino Biologics', adopting a different technique, has entered a Phase II trial involving those aged between six and 17.

Sinovac has also completed a Phase II clinical trial where participants were injected with a third booster dose after completing two regular shots, Yin said.

Participants saw 10 fold increase in antibody levels compared with previous levels in a week, and 20 fold in half a month, Yin said.

Yin cautioned that Sinovac still needs to complete longer-term observation of antibody duration before it can make recommendation to authorities about when a third dose should be given. Reuters

Top Stories

No need at the moment to change Covishield doses gap: Vaccine task force experts

No need at the moment to change Covishield doses gap: Vaccine task force experts

'Basic principle is that our people should get the maximum b...

Navjot Sidhu denies any joint meeting with Kharge panel or party high command

Navjot Sidhu denies any joint meeting with Kharge panel or party high command

Says it is propaganda against him by his detractors

India records less than 50,000 new Covid cases, lowest in 91 days

India records less than 50,000 new Covid cases, lowest in 91 days

Active cases fall below 7 lakh after 79 days

J-K's Gupkar alliance to attend Centre's all-party meeting

J-K's Gupkar alliance to attend Centre's all-party meeting

The announcement comes after PAGD leaders hold a meeting

SIT begins questioning of former Punjab CM Parkash Singh Badal in Kotkapura firing case

SIT begins questioning of former Punjab CM Parkash Singh Badal in Kotkapura firing case

A team lead by ADGP LK Yadav is quizzing the former Chief Mi...

Cities

View All